Agilent Technologies Inc (NYSE:A) shares climbed 19% on Thursday after the company posted stronger-than-expected fiscal second quarter results and received an upgrade from Bank of America, which pointed to improving demand trends and continued market share gains in key instrument categories.
Bank of America upgraded Agilent to ‘Buy’ from ‘Neutral,’ saying the company is showing “strong execution” despite uneven conditions across several end markets.
Dell Technologies Inc (NASDAQ:DELL) shares rose about 7% on Wednesday after the US Department of Defense announced a five-year, approximately $9.7 billion enterprise software agreement involving Dell Federal Systems to provide and manage Microsoft-related software and cloud services for the US military and affiliated agencies.
The contract, awarded following a competitive procurement process, will supply Microsoft 365, advanced cloud subscriptions, and on-premises licensing capabilities.
Kohl's Corporation (NYSE:KSS) reported first quarter 2026 results that showed a smaller-than-expected loss and better-than-anticipated revenue and sales trends, sending its shares up about 17% on Thursday.
For the quarter ended May 2, 2026, Kohl’s posted a diluted loss of $0.13 per share, beating Wall Street expectations for a loss of $0.21 per share.
Best Buy Co Inc (NYSE:BBY) shares jumped 17% after the retailer’s first quarter earnings topped Wall Street expectations and the company reaffirmed its full-year outlook.
The company reported adjusted earnings per share of $1.28, topping analyst estimates of $1.22, while total revenue rose to $8.94 billion, above expectations of $8.82 billion.
Dollar Tree, Inc. (NASDAQ:DLTR) shares jumped almost 18% on Thursday morning after the discount retailer reported stronger-than-expected earnings and upwardly revised its full-year profit guidance.
Adjusted earnings per share were $1.74, above analyst expectations of $1.55.
HP Inc (NYSE:HPQ) shares were trading 2% lower on Thursday after the personal computing and printing giant reported second-quarter results that topped Wall Street estimates but trimmed its full-year profit outlook, with rising memory costs and slowing unit demand clouding the near-term picture.
The company posted non-GAAP earnings per share of $0.86 for the second quarter, well above its prior guidance range of $0.70 to $0.76. Total revenue rose 9% year-over-year to approximately $14.4 billion, marking the eighth consecutive quarter of top-line growth.
AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) has announced the launch of a new Patient Impact Grant Program aimed at supporting non-profit organizations working to improve mental health outcomes through community initiatives, education and research.
The clinical-stage biotechnology company said the program will award three grants of $20,000 each to mission-driven organizations focused on advancing mental health support and patient outcomes.
Synopsys Inc (NASDAQ:SNPS, XETRA:SYP) reported fiscal second quarter results above Wall Street expectations, with adjusted earnings and revenue both exceeding forecasts and the company lifting its full-year guidance.
Adjusted earnings per share came in at $3.35, topping consensus estimates of $3.15, while revenue rose 41.9% year-over-year to $2.28 billion, above the expected $2.25 billion.
Medicus Pharma (NASDAQ:MDCX) announced on Thursday that it has entered into a definitive financing agreement with an institutional investor for an up to $22 million structured, non-dilutive financing facility aimed at supporting its clinical development programs and extending its cash runway.
The biotech and life sciences company said the financing is expected to increase its pro forma cash position to about $30 million and provide projected operating liquidity for more than 24 months.
Giyani Metals Corp (TSX-V:EMM, OTC:CATPF, FRA:KT9) has released a definitive feasibility study for its K.Hill battery-grade manganese project in Botswana, which outlined a projected post-tax net present value of $481.5 million and an internal rate of return of 20.3%.
The study covers the company’s 100%-owned K.Hill project in the Kanye Basin and supports the declaration of mineral reserves for the planned open-pit mine and hydrometallurgical processing facility.
Immunic Inc (NASDAQ:IMUX, FRA:10VA) said on Thursday it presented three posters at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting in Charlotte, North Carolina, including a late-breaking analysis of its lead drug candidate vidofludimus calcium in patients with progressive multiple sclerosis.
The late-breaking poster introduced a novel unified endpoint called Confirmed Disability Change, designed to capture both disability worsening and improvement within a single statistical framework.
Pulsar Helium Inc (LSE:PLSR) shares moved up, gaining 4.8% changing hands at 83.2p, after new Minnesota legislation created a clearer route toward production at its flagship Topaz helium project, as the company moves from appraisal work into production-well planning.
The AIM, TSX-V and OTCQB-listed company noted that Governor Tim Walz signed the legislation on May 26, updating state processes for permitting gas extraction projects and advancing a helium-specific framework in northeastern Minnesota.